A guide to the treatment of depression in women by estrogens

Climacteric

Volumn 14, Issue 6, 2011, Pages 637-642

  Studd, J W ^a  

^a London PMS and Menopause Centre   (United Kingdom)

Author keywords

bipolar disorder; estrogens; perimenopausal depression; postnatal depression; premenstrual depression; testosterone

Indexed keywords

ANTIDEPRESSANT AGENT; CONJUGATED ESTROGEN; CYPROTERONE ACETATE; DROSPIRENONE PLUS ETHINYLESTRADIOL; ESTRADIOL; ESTROGEN; GESTAGEN; GONADORELIN DERIVATIVE; LEVONORGESTREL; NORETHISTERONE; PROGESTERONE; SEROTONIN UPTAKE INHIBITOR; TESTOSTERONE; UNCLASSIFIED DRUG; VELOFLAXINE;

BIPOLAR DISORDER; BLEEDING; BLOATING; CLIMACTERIUM; DEPRESSION; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DRUG DOSE INCREASE; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; ENDOMETRIUM HYPERPLASIA; ENERGY; ESTROGEN THERAPY; FATIGUE; FEMALE; GEL; HUMAN; HYSTERECTOMY; INVOLUTIONAL DEPRESSION; LIBIDO; LIBIDO DISORDER; MEDICATION ERROR; MENSTRUAL CYCLE; MOOD; OVARIECTOMY; OVULATION INHIBITION; PREGNANCY; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; PSYCHOSEXUAL DISORDER; PUERPERAL DEPRESSION; RECOMMENDED DRUG DOSE; REVIEW; SELF ESTEEM; SEXUAL BEHAVIOR; TRANSDERMAL PATCH; TREATMENT DURATION; TREATMENT RESPONSE; VEIN THROMBOSIS;

DEPRESSION, POSTPARTUM; DEPRESSIVE DISORDER; ESTROGENS; FEMALE; HUMANS; PERIMENOPAUSE; PREMENSTRUAL SYNDROME;

EID: 81755178294     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2011.609285     Document Type: Review

References (50)

1. Studd JW. Why are estrogens rarely used for the treatment of depression in women? Gynecol Endocrinol 2007;23:63-4
2. Writing Group for the Women' s Health Initiative investigators. Risks and benefi ts of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;228:321-33
3. Anderson GL, Limacher M, Assaf AR, et al . Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women ' s Health Initiative randomized controlled trial. JAMA 2004;291:1701-12 (Pubitemid 38489892)
4. Renoux C, Dell' Aniello S, Garbe E, Suissa S. Transdermal and oral hormone replacement therapy and the risk of stroke. BMJ 2010;340:c2519
5. Studd J, Panay N. Hormones and depression in women. C limacteric 2004;7:338-46 (Pubitemid 40018327)
6. Watson NR, Studd JWW, Savvas M, Garnett T, Baber RJ. Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone. Lancet 1989;8665:730-2 (Pubitemid 19243126)
7. Smith RNH, Studd JWW, Zamblera D, Holland EFN. A randomised comparison over 8 months of 100 micrograms and 200 micrograms twice weekly doses of transdermal oestradiol in the treatment of severe premenstrual syndrome. Br J Obstet Gynaecol 1995;102:475-84
8. Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW. Transdermal estrogen for the treatment of severe post-natal depression. Lancet 1996;347:930-3 (Pubitemid 26102548)
9. Ahokas A, Kaukoranta J, Wahlbeck K, Aito M. Estrogen defi - ciency in severe postpartum depression: successful treatment with sublingual physiologic 17beta-estradiol a preliminary study. J Clin Psychiatry 2001;62:332-6 (Pubitemid 32545553)
10. Montgomery JC, Brincat M, Tapp A, et al . Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet 1987;I:297-9 (Pubitemid 17018638)
11. Soares CN, Almeida, Joff H, Cohen LS. Effi cacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2001;58:529-34 (Pubitemid 32523731)
12. Rasgon NL, Alshuler LL, Fairbanks LA et al. Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women . J Clin Psychiatry 2002;63(Suppl 7): 545-8
13. Studd J, Panay N. Are oestrogens useful for the treatment of depression in women? Best Pract Res Clinic Obstet Gynaecol 2009;23:63-71
14. Mojtabai R. Increase in antidepressant medication in the US adult population between 1990 and 2003. Psychother Psychosom 2008;77:83-92
15. Smoller JW, Allison M, Cochrane BB, et al . Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women ' s Health Initiative Study. Arch Intern Med 2009;169:2128-39
16. Morrison MF, Kallan MJ, Ten Have T, Katz I, Tweedy K, Battistini M. Lack of effi cacy of oestradiol for depression in postmenopausal women: a randomised controlled trial. Biol Psychiatry 2004;55:406-12 (Pubitemid 38199991)
17. Fornaro M, Perugi G. The impact of premenstrual dysphoric disorderamong 92 bipolar patients. Eur Psychiatry 2010;8:450-4
18. Soares CN, Zitek B. Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability? J Psychiatry Neurosci 2008;33:331-43 (Pubitemid 351977159)
19. Klaiber EL, Broverman DM, Vogel W, Kobayashi Y. Estrogen therapy for severe persistent depressions in women. Arch Gen Psychiatry 1979;36:550-4 (Pubitemid 9201186)
20. Panay N, Studd J. Progestogen intolerance and compliance with hormone replacement therapy in menopausal women. Hum Reprod Update 1997;3:159-71 (Pubitemid 27389987)
21. Magos AL, Brewster E, Singh R, O' Dowd T, Brincat M, Studd JWW. The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome. Br J Obstet Gynaecol 1986;93: 1290-6 (Pubitemid 17196573)
22. Rapkin AJ. Yaz in the treatment of premenstrual dysphoric disorder. J Reprod Med 2008;53:729-41
23. Yonkers KA, O' Brien PM, Eriksson E. Premenstrual syndrome. Lancet 2008;371:1200-10 (Pubitemid 351458526)
24. Studd J. Suppression of ovulation for the treatment of severe premenstrual depression. Menopause Int 2007;13:182-4
25. Studd J, Magos AL. Hormone pellet implantation for menopause and premenstrual syndrome. Obstet Gynecol Clin North Am 1987;14:224-49
26. Leather AT, Studd JW, Watson NR, Holland EF. The treatment of severe premenstrual syndrome with goserelin with and without - add-back ' estrogen therapy: a placebo-controlled study. Gynecol Endocrinol 1999;13:48-55 (Pubitemid 29265520)
27. Sundstrom I, Nyberg S, Bixo M, Hammarback S, Backstrom T. Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen. Acta Obstet Gynecol Scand 1999;78:891-9
28. Wyatt KM, Dimmock PW, Ismail KM, Jones PW, O' Brien PM. The effectiveness of GnRH analogue with and without " addback " therapy in treating premenstrual syndrome: a meta analysis. BJOG 2004;111:585-93 (Pubitemid 38746243)
29. O ' Brien PMS, Ismail KMK. History of premenstrual disorders. In O ' Brien PMS, Rapkin A, Schmidt P, eds. The Premenstrual Syndromes: PMS and PMDD . London: Informa Healthcare, 2007:1-8
30. Leather AT, Studd JWW, Watson NR, Holland EFN. The prevention of bone loss in young women treated with GnRH analogues with - 104 - add back ' oestrogen therapy. Obstet Gynecol 1993; 81:104-7 (Pubitemid 23041712)
31. Di Carlo C, Palomba S, Tommaselli GA et al. Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome. Fertil Steril 2001;76:850-2
32. Elovainio M, Teperi J, Aalto AM. Depressive symptoms as predictors of discontinuation of levonorgestrel releasing intrauterine system. Int J Behav Med 2007;14:70-5 (Pubitemid 47021042)
33. Sands R, Studd J. Exogenous androgens in postmenopausal women . Am J Med 1995;98:76-9
34. Davis SR. Androgen treatment in women. M ed J Aust 1999; 170:545-9 (Pubitemid 29261613)
35. Cronje WH, Vashisht A, Studd JW. Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome. Hum Reprod 2004;19:2152-5 (Pubitemid 39236487)
36. Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 2000;157:924-30 (Pubitemid 30412343)
37. Moses-Kolko EL, Berga SL, Kalro B, Sit DK, Wisner KL. Transdermal estradiol for postpartum depression: a promising treatment option. Clin Obstet Gynecol 2009;52:516-29
38. Lawrie TA, Hofmeyr GJ, De Jager M, et al. A double blind randomised placebo controlled study of postnatal norethisterone enanthate: the effect on postnatal depression and hormones. Br J Obstet Gynaecol 1998;105:1082-90 (Pubitemid 28461501)
39. Dennis CL, Ross LE, Herxheimer A. Oestrogens and progestins for preventing and treating postpartum depression. Cochrane Database Syst Rev 2008;(4):CD001690
40. Carroll DG, Kelley KW. Use of antidepressants for management of hot fl ushes. Pharmacotherapy 2009;29:1357-66
41. Dennerstein L, Lehert P, Burger H, et al . Mood and the menopausal transition. J Nerv Ment Dis 1999;187:685-91
42. Soares CN, Frey BN. Challenges and opportunities to manage depression during the menopausal transition and beyond. Psychiatr Clin North Am 2010;33:295-308
43. Graziottin A, Serafini A. Depression and the menopause: why antidepressants are not enough? Menopause Int 2009;15:76-81
44. Brincat M, Magos A, Studd JW et al. Subcutaneous hormone implants for the control of climacteric symptoms. A prospective study. Lancet 1984;1(8367):16-18 (Pubitemid 14213482)
45. Vashisht A, Wadsworth F, Carey A, Carey B, Studd J. A study to look at hormonal absorption of progesterone cream used in conjunction with transdermal estrogen. Gynecol Endocrinol 2005;21:101-5 (Pubitemid 41345503)
46. Gath D, Rose N, Bond A, Garrod A, Hodges S. Hysterectomy and psychiatric disorder: are the levels of psychiatric morbidity falling? Psychol Med 1995;25:277-83
47. Panay N, Studd JW. The psychotherapeutic effects of estrogens. Gynecol Endocrinol 1998;12:353-65 (Pubitemid 28561456)
48. Fink G, Sumner BE. Oestrogen and mental state. Nature 1996;383:306
49. Khastgir G, Studd J. Patients' outlook, experience and satisfaction with hysterectomy, bilateral oophorectomy, and subsequent continuation of hormone replacement therapy. Am J Obstet Gynecol 2000;183:1427-33 (Pubitemid 32061203)
50. Paterson M, Wade-Evans T, Sturdee DW, Thom MH, Studd JW. Endometrial disease after treatment with oestrogens and progestogens in the climacteric. Br Med J 1980;280:822-4 (Pubitemid 10147113)